Abstract
There is a large variability in drug response that can be attributed in part to the patient’s lack of adherence to treatment. Low adherence is common and can reach 30% of prescriptions in general and 50% in chronic diseases. Several self-report questionnaires are used to assess adherence, however, their use in clinical practice has been quite limited. Hydroxychloroquine (HCQ) has an excep…